Overview
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine
Current Appointments & Affiliations
Professor of Medicine
·
2021 - Present
Medicine, Cardiology,
Medicine
Member in the Duke Clinical Research Institute
·
2009 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
Journal Article Am Heart J · April 2025 BACKGROUND: SGLT-2i and GLP-1RA are recommended for persons with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD); for those prescribed, little is known about reasons for discontinuation. METHODS: From the COORDINATE-Diabetes randomized t ... Full text Link to item CiteEffect of Telemedicine Interventions on Heart Failure Hospitalizations: A Randomized Trial.
Journal Article J Am Heart Assoc · March 7, 2025 BACKGROUND: Telemedicine interventions (TMIs) for heart failure (HF) can reduce hospitalizations and deaths. It is unclear if low literacy and limited access to technology in low- and middle-income countries affect these benefits. We evaluated whether TMIs ... Full text Link to item CiteEffect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS.
Journal Article Am Heart J · February 2025 BACKGROUND: Clinical trials of antithrombotic agents typically use separate time-to-event analyses for bleeding and ischemic events, but this framework has limitations. Days alive and out of hospital (DAOH) is an alternative that may provide additional ins ... Full text Link to item CiteRecent Grants
A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical TrialPrincipal Investigator · Awarded by Parexel International LLC · 2021 - 2029Priovant BREPO
Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2022 - 2027Phase II and III Cardiovascular Adjudication Program for Evaluation of Efficacy and Safety of VDPHL01
Clinical TrialPrincipal Investigator · Awarded by VeraDermics Inc. · 2025 - 2027View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2009
M.H.S.
Paulista Medical School, University of Sao Paulo (Brazil) ·
2006
Ph.D.
University of Santo Amaro (Brazil) ·
2001
M.D.